A top-selling diabetes drug from Novo Nordisk beat out placebo in reducing blood sugar in children with Type 2 diabetes, according to data published Sunday in the New England Journal of Medicine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,